Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 146,101 $ 955,563
Short-term investments 910,692 343,248
Total cash, cash equivalents and short-term investments 1,056,793 1,298,811
Restricted cash 3,204 0
Other receivables 4,021 2,315
Prepaid expenses and other current assets 20,160 17,416
Total current assets 1,084,178 1,318,542
Property and equipment, net 92,103 53,155
Operating lease right-of-use assets 25,149 0
Restricted cash 762 762
Equity method investment 0 20,306
Intangible assets 12,581 14,512
Goodwill 14,011 10,757
Other non-current assets 64,200 70,321
Total assets 1,292,984 1,488,355
Current liabilities    
Accounts payable 7,710 3,637
Operating lease liabilities, current portion 3,710 0
Accrued expenses and other current liabilities 18,783 10,211
Total current liabilities 30,203 13,848
Operating lease liabilities, net of current portion 23,613 0
Stock repurchase liability 378 711
Warrant liability 28,783 44,902
Earnout shares liability 44,055 109,844
Other non-current liabilities 1,211 2,291
Total liabilities 128,243 171,596
Commitments and contingencies (Note 9)
Stockholders’ equity:    
Preferred stock: $0.0001 par value - 100,000,000 shares authorized at December 31, 2022 and 2021. No shares issued and outstanding at December 31, 2022 and 2021. 0 0
Common stock: $0.0001 par value - 1,400,000,000 shares authorized at December 31, 2022 and 2021, 622,602,815 and 604,174,329 shares issued and outstanding at December 31, 2022 and 2021, respectively 61 60
Additional paid-in capital 1,908,179 1,793,431
Accumulated deficit (734,653) (476,610)
Accumulated other comprehensive loss (8,846) (122)
Total stockholders’ equity 1,164,741 1,316,759
Total liabilities and stockholders’ equity $ 1,292,984 $ 1,488,355